We are live on ! Find out more
RAIN

Rain Oncology Inc. Common Stock
RAIN

Delisted

RAIN was delisted on the 25th of January, 2024.

Back to rankings

40 hedge funds and large institutions have $77.7M invested in Rain Oncology Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 5 increasing their positions, 15 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more capital invested

Capital invested by funds: $75.1M → $77.7M (+$2.62M)

18% less funds holding

Funds holding: 49 → 40 (-9)

37% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 19

67% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 15

Holders
40
Holders Change
-9
Holders Change %
-18.37%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
5
Reduced
15
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
+$1.14M
2
LCM
Laurion Capital Management
New York
+$1.08M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$329K
4
E
Ergoteles
New York
+$243K
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$234K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$2.27M
2
LGM
Logos Global Management
California
-$680K
3
State Street
State Street
Massachusetts
-$578K
4
Victory Capital Management
Victory Capital Management
Texas
-$499K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$421K
Name Holding Trade Value Shares
Change 		Change in
Stake
First Trust Advisors
26
First Trust Advisors
Illinois
$62K -$923 -269 -2%
Citadel Advisors
27
Citadel Advisors
Florida
$57K +$35.6K +10,362 New
Goldman Sachs
28
Goldman Sachs
New York
$56K -$22.6K -6,583 -40%
LFM
29
Lumina Fund Management
New York
$33K – – –
TRCT
30
Tower Research Capital (TRC)
New York
$6K -$3.37K -982 -48%
Wells Fargo
31
Wells Fargo
California
$6K -$2.19K -639 -38%
JP Morgan Chase
32
JP Morgan Chase
New York
$4K -$30.6K -8,928 -93%
PCG
33
Private Capital Group
Connecticut
$3K +$1.82K +530 New
Citigroup
34
Citigroup
New York
$2K -$2.88K -838 -66%
GRP
35
Global Retirement Partners
California
$2K – – –
New York State Common Retirement Fund
36
New York State Common Retirement Fund
New York
$1K -$21.6K -6,300 -98%
Northwestern Mutual Wealth Management
37
Northwestern Mutual Wealth Management
Wisconsin
$1K +$687 +200 New
LGM
38
Logos Global Management
California
– -$680K -134,194 Closed
Victory Capital Management
39
Victory Capital Management
Texas
– -$499K -98,480 Closed
Bank of New York Mellon
40
Bank of New York Mellon
New York
– -$186K -36,728 Closed
Charles Schwab
41
Charles Schwab
California
– -$175K -34,429 Closed
N
42
Nuveen
North Carolina
– -$223K -32,437 Closed
TI
43
Trexquant Investment
Connecticut
– -$144K -28,373 Closed
Two Sigma Investments
44
Two Sigma Investments
New York
– -$102K -20,172 Closed
Two Sigma Advisers
45
Two Sigma Advisers
New York
– -$68K -13,500 Closed
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
– -$57K -11,319 Closed
Deutsche Bank
47
Deutsche Bank
Germany
– -$44K -8,651 Closed
AIG
48
American International Group
New York
– -$40K -7,899 Closed
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
– -$35K -6,847 Closed
Barclays
50
Barclays
United Kingdom
– -$13K -2,616 Closed
1
2
3

RAIN Hedge Fund Activity: Q2 2022 in Review

40 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Rain Oncology Inc. Common Stock (RAIN) for Q2 2022, worth a combined $77.7M — up 3.5% from $75.1M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of RAIN and 12 opened new positions — a net loss of 7 holders — while 15 trimmed existing stakes and 5 added.

The largest buyer was UBS O'Connor, opening a new position worth an estimated $1.14M. The largest seller was BlackRock, cutting an estimated $2.27M.

  • 40 institutional investors held Rain Oncology Inc. Common Stock (RAIN) as of Q2 2022, down from 49 in Q1 2022.
  • Funds reported $77.7M of Rain Oncology Inc. Common Stock stock for Q2 2022, up 3.5% quarter-over-quarter.
  • 12 funds opened new Rain Oncology Inc. Common Stock positions in Q2 2022 and 19 closed out, a net change of -7 holders.
  • The largest Rain Oncology Inc. Common Stock buyer in Q2 2022 was UBS O'Connor, an estimated $1.14M added.
  • The largest Rain Oncology Inc. Common Stock seller in Q2 2022 was BlackRock, an estimated $2.27M sold.

Based on aggregated 13F filings for Q2 2022.